Search
Sumario de resultados
TIpos de contenido
Fecha
-
New#BIOSPAIN2023 Interview | "Entrepreneurial activity in Spain is lower, but more resilient ...
We analyze Spain's entrepreneurial capacity under the brand Spain Up Nation, an initiative of the Government of Spain and Platinum Sponsor of BIOSPAIN 2023, with José Bayón, CEO.
-
New#BIOSPAIN2023Interview | "Biotech SMEs focus on projects with no mid-term cash generation,...
We discuss the launch of BME Scale, a new market primarily aimed at "scale-ups," with Jesús González, Managing Director of BME Growth, a Bronze Sponsor of BIOSPAIN 2023.
-
NewBIOSPAIN 2023: Biotechnology emerges as a response to the main challenges Europe is facing
The new edition of the international flagship event in the biotech sector will take place in Barcelona from September 26 to 28, in collaboration with Biocat, the Government of Catalonia, and the
-
Press releaseBIOSPAIN 2023: Biotechnology emerges as a response to the main challenges Europe is facing
The new edition of the international flagship event in the biotech sector will take place in Barcelona from September 26 to 28, in collaboration with Biocat, the Government of Catalonia, and the
-
New#BIOSPAIN2023Interview | "The 'biotech' sector is one of the sectors with the greatest fin...
We spoke with Cristina Cortés, manager at Ayming, Bronze Sponsor of BIOSPAIN 2023, about the role of private financing in the biotechnology sector.
-
New#BIOSPAIN2023Interview | "In Spain, there are still few researchers who venture to turn th...
We spoke with Raúl Martín-Ruiz, partner at Ysios Capital, Gold Sponsor of BIOSPAIN 2023, about how to transform scientific knowledge into a successful company and the major challenges that
-
New#BIOSPAIN2023 Interview | "The Administration of LAM561 Shows Promising Results in the Tr...
We spoke with Cati Ana Rosselló, Head of CMC at Laminar Pharma, a Bronze Sponsor of BIOSPAIN 2023, about the results of the LAM561 trials against glioblastoma.
-
NewGradient Denervation Technologies closes €14m Series A led by Sabadell Asabys
The funds will enable the company to advance the clinical development of its unique, minimally invasive ultrasound-based catheter for the treatment of pulmonary hypertension, with initial focus on the
-
New#BIOSPAIN2023Interview | "It is good news that the CNMV has laid the foundations to measu...
We spoke with Clara Campàs, director and co-founder of Asabys, Gold Sponsor of BIOSPAIN 2023, to learn all the details about the launch of the Sabadell Asabys Health Innovation Investments II (SAHII 2
-
NewBiorepository expands its facilities in Rivas Vaciamadrid
The Galician company continues its national projection responding to the specific needs of its customers.
-
NewShapingBio will analyze the challenges and opportunities of the bioeconomy in Europe at BI...
The European project ShapingBio, created with the aim of better understanding and enhancing knowledge of the innovation ecosystem in the European bioeconomy sector, will be present at BIOSPAIN.
-
Press releaseShapingBio will analyze the challenges and opportunities of the bioeconomy in Europe at BI...
The European project ShapingBio, created with the aim of better understanding and gaining knowledge of the innovation ecosystem in the European bioeconomy sector, will be present at BIOSPAIN. Under
-
NewThe Galician biopharmaceutical Oncostellae opens an office at the Barcelona Science Park
The company specialises in the development of molecules for oncological and gastrointestinal immunological treatments and has a drug in clinical phase IIa for ulcerative colitis and one in clinical
-
NewBarcelona Science Park companies break record after raising €142M in 2022
2022 has been a historic year in economic and innovation indicators for the ecosystem of companies that form part of the Barcelona Science Park (PCB), comprising more than 124 entities. The funding
-
New#BIOSPAIN2023Interview | "We are facing a paradigm shift in Drug Discovery"
Víctor Guallar, Chief Scientific Officer of Nostrum Biodiscovery, Silver Sponsor of BIOSPAIN 2023, analyzes the current situation of Drug Discovery.
-
NewIntegra Therapeutics to present ex vivo and in vivo data for its FiCAT gene-writing platfo...
The data shows the potential FiCAT technology holds, writing large and small genes to design safe, effective cell and gene therapies, and opens the door to the regulatory phase.
-
NewORYZON to give updates on corporate progress in September
The international conferences that will be attended include the H.C. Wainwright Global Investment Conference in New York, the Sachs Annual Biotech in Europe Forum in Basel, the Annual Global CMT
-
New#BIOSPAIN2023Interview | "Patients with a rare disease face a large number of unmet needs"
We talk about the role of patients in developing solutions for rare diseases with Annabel de Maria, Chief Patient Officer at Alira Health, Gold Sponsor of BIOSPAIN 2023.
-
NewNLP will allow important advances in all fields, and especially in the field of health
Natural language processing (NLP) systems are a key branch of artificial intelligence that allows machines to understand, interpret and generate human language in a more sophisticated way.
-
New#BIOSPAIN2023Interview | "In Spain, there is a misconception that public and private fundi...
We talk about innovation in the technology sector with Natalia de la Figuera and Josep Lluís Falcó, founding partners of GÉNESIS Biomed, silver sponsor of BIOSPAIN 2023.
-
New#BIOSPAIN2023Interview | "It is necessary to increase investment ratios in R&D through pub...
We spoke with Mariona Sanz Ausàs, Head of Innovation and Business Development at BSC, Silver Sponsor of BIOSPAIN 2023, about the company's role in technology transfer in the biotechnology sector.